Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics (PROSPECT): a National, Multicenter, Retrospective-prospective, Cohort Study

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The etiology and specific pathogenesis of many cardiovascular diseases such as coronary atherosclerosis, cardiomyopathy, atrial fibrillation, and stroke are still unclear. Improving diagnosis and treatment, clarifying the pathogenesis, and providing scientific basis for the prevention and treatment are hot research topics in the study of cardiovascular and cerebrovascular diseases. This study intends to collect clinical data and biological specimen data of patients with cardiovascular and cerebrovascular diseases who meet the inclusion and exclusion criteria, and use multi-omics technology to deeply understand the pathogenic mechanisms of cardiovascular and cerebrovascular diseases and provide new ideas for specific and individualized treatment of patients with cardiovascular and cerebrovascular diseases, to construct early predictive prognostic models and provide a basis for effective treatment of clinical practice in patients with cardiovascular and cerebrovascular diseases.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 3
Maximum Age: 80
Healthy Volunteers: f
View:

• Patients who are regularly visited and followed up in the appropriate patient; department.

• All patients met at least one of the following diagnostic criteria for cardiovascular and cerebrovascular diseases:

• coronary artery disease group;

• arrhythmia group;

• heart valve disease group;

• aortic dissection group;

• cardiac masses group;

• myocarditis group;

• hypertension group;

• cardiomyopathy group;

• structural heart disease group;

• ischemic cerebrovascular disease group;

• hemorrhagic cerebrovascular disease group;

• intracranial space occupying lesion group.

Locations
Other Locations
China
First Affiliated Hospital of Xian Jiantong University
RECRUITING
Xi'an
Contact Information
Primary
Gouliang Li
liguoliang_med@163.com
13759982523
Backup
Yang Yan
yangyan3@xjtu.edu.cn
13259882601
Time Frame
Start Date: 2022-12-05
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 25000
Treatments
Coronary artery disease group
Diagnosis of coronary artery disease by clinical guidelines.
Arrhythmia group
Diagnosis of arrhythmia by clinical guidelines. by clinical guidelines.
Heart valve disease group
Diagnosis of heart valve disease by clinical guidelines.
aortic dissection group
Diagnosis of aortic dissection by clinical guidelines.
Cardiac masses group
Diagnosis of cardiac messes by clinical guidelines.
Myocarditis group
Diagnosis of myocarditis by clinical guidelines.
Hypertension group
Diagnosis of hypertension by clinical guidelines.
Cardiomyopathy group
Diagnosis of cardiomyopathy by clinical guidelines.
Structural heart disease group
Diagnosis of structural heart disease by clinical guidelines.
Ischemic cerebrovascular disease group
Diagnosis of ischemic cerebrovascular disease by clinical guidelines.
Hemorrhagic cerebrovascular disease group
Diagnosis of hemorrhagic cerebrovascular disease by clinical guidelines.
Intracranial space occupying lesion group
Diagnosis of intracranial space occupying by clinical guidelines.
Sponsors
Collaborators: First Affiliated Hospital of Chongqing Medical University, Xi'an Gaoxin Hospital, General Hospital of Ningxia Medical University, Second Affiliated Hospital of Nanchang University
Leads: First Affiliated Hospital Xi'an Jiaotong University

This content was sourced from clinicaltrials.gov